Chiron Real Estate Inc.
XRN · Price history
Price at last available close
$28.96
−$6.46 (-18.24%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Chiron Real Estate Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
How they make money
Chiron Real Estate Inc. is an internally managed REIT that generates revenue primarily through the collection of annualized base rent from healthcare facilities. The company acquires and leases medical office buildings, inpatient rehabilitation facilities, and surgical hospitals to physician groups and healthcare systems under triple-net, gross, and modified-gross lease structures.
Products & services
Ownership and leasing of healthcare real estate properties, including medical office buildings, inpatient rehabilitation facilities, and surgical hospitals.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- Property management and maintenance service providers — The company utilizes various third-party service providers for the maintenance and operation of its healthcare facilities; specific supplier names are not disclosed.Source
Business relationships & partnerships
- Heitman — The company maintains a joint venture with Heitman, a real estate investment firm, in which Chiron serves as the managing member.Source
Strengths
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
45
Weak
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
32
Poor
Financial Strength
44
Business Quality / Moat
7
Management
53
Growth Quality
20
Risk / Durability
32
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
81
Attractive
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
70/100
Building Historical Record
Model Score 70/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as relatively attractive.
The model outlook is currently positive.
- •Valuation scores attractively
- •Insider activity signal is favorable
- •Recent buyback activity is present
- •High debt risk
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for XRN
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving XRN's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •How long can XRN fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Is XRN's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •Is XRN's valuation discount tied to a temporary concern or to a longer-term business risk?
- •What does the current high debt stress warning mean for the reliability or interpretation of XRN's score?
Essential Investment Snapshot
Wall Street Score
45
Opportunity Score
81
Market Cap
$383.4M
P/E Ratio
8.8
EPS
$3.91
52-Week High
$38.65
52-Week Low
$29.05
Beta
1.13
Intrinsic Value
$76.18
Analyst Target
$41.50
Shares Outstanding
13.4M
Total Revenue
$156.8M
Total Debt
$636.9M
Dividend Yield (TTM)
7.94%
Liquidation Value / Share
$51.13
Dividend / Share (TTM)
$2.30
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for XRN
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
High debt risk
Total debt is at least one year of revenue • Interest coverage is below 2x • Free cash flow is negative • Cash covers less than 20% of total debt
Community Sentiment
0 active · 0 total callsNo personal call yet on XRN.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Internally managed REIT structure.
- +Diversified portfolio of healthcare facilities.
Potential downside factors
- −Debt risk (high): Total debt is at least one year of revenue.
- −Interest coverage is below 2x.
- −Free cash flow is negative.
- −Cash covers less than 20% of total debt.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
15
Jul 24, 2026
Change
+30.2
points
Current Score
45
Oct 1, 2026
Category Changes
XRN increased 30.2 points because Revenue improved by 27.8 points, Asset improved by 6.2 points, Capital improved by 59 points.
Positive Contributors
- + Revenue improved by 27.8 points
- + Asset improved by 6.2 points
- + Capital improved by 59 points
- + Management improved by 38.7 points
- + Moat improved by 6.7 points
- + Valuation improved by 100 points
- + Buffett improved by 23.3 points
Projected Score
Projected Score
55
Projected Change
+10.4 points
Preliminary comparable-period financial changes suggest improvement of approximately 10.4 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$28.96
Model Intrinsic Value
$76.18
Difference
−$47.22
-62.0% vs IV
Margin of Safety
62.0%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $156.8M | $161.0M | $138.4M | $140.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $156.2M | $150.7M | $29.3M | $28.1M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $608K | $10.3M | $109.2M | $112.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $30.0M | $20.0M | $21.1M | $16.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | -$39.4M | -$39.0M | $76.5M | $75.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $158.7M | $96.7M | $91.5M | $111.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $40.0M | $49.4M | $32.7M | $37.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $36.0M | $44.6M | $28.7M | $30.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $62.7M | -$6.9M | $6.7M | $21.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $57.9M | -$5.8M | $6.6M | $20.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $3.91 | $-0.91 | $0.31 | $5.75 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 13.23M | 13.38M | 2.64M | 2.62M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 13.23M | 13.38M | 2.64M | 2.62M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$39.7M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$4.78
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-55.5%
Cash Change
+62.0%
Margin Change
+165.1 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
- Debt reduced
Potential Score Impact
Positive indicators included EPS growth, cash levels, debt levels, net income margin. Pressure indicators included revenue growth. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue declined 3.7%. EPS increased 9460.0%. Cash increased 62.0%. Total debt declined 55.5%. Net income margin improved by 165.1 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Log in to view dividend history.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
2 historical records2 historical score records available.
Historical Score Chart
2 of 2 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
REIT - Healthcare FacilitiesNews
Global Medical REIT Inc. (NYSE:XRN) Stock Has Average Price Target of $40.17
Brokerages Set Global Medical REIT Inc. (NYSE:XRN) PT at $39.60
Chiron Real Estate Inc. Announces Employee Inducement Awards Under NYSE Rule 303A.08
Chiron Real Estate: A Transformation The Market Still Underestimates
Rumor Mill · XRN
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial